ImClone’s earnings fall as drug faces competition (The Star-Ledger)
Tuesday, July 31st, 2007ImClone Systems, a biotechnology company with operations in New Jersey, said yesterday second-quarter earnings fell as competition bit into sales of its cancer drug Erbitux.
Original post by Lyle